Business programme

Director of the Medical Research and Educational Centre of the Lomonosov Moscow State University, Head of the Urology and Andrology School of the Department of Fundamental Medicine of the Lomonosov Moscow State University, Academician of the Russian Academy of Sciences, Professor, Doctor of Medicine, Honoured Scientist of the Russian Federation.
The central focus of scientific research and practice:
Armais Kamalov’s scientific research focuses on urology, andrology and fundamental medicine. He is the author of many research papers, including monographs, textbooks, books, manuals, and patents for inventions. He is the author of many research papers, including monographs, textbooks, books, manuals, and patents for inventions. He was a scientific advisor of 5 doctoral and ten master’s theses. In 1992, he passed Candidate’s thesis defence, in 1998 – PhD thesis defence. Both focused on scientific rationale and introduction of radically new endoscopic methods of treatment of urological diseases.
Many years of scientific research and medical practice Armais Kamalov devoted to the development and implementation of high-tech minimally invasive methods of diagnosis and treatment of urological diseases, which significantly improved the outcome of treatment of many urological disorders.
In recent years, he has been devoting much attention to establishing a new medicine based on an interdisciplinary approach to solving men's health problems and improving reproductive health. Through his direct involvement, the organization of a programme to protect the health of the male population, including the setting up specialized medical clinics was successfully implemented in the regions of the Russian Federation.
Honours, awards
• Medal for Labour Valour (1997)
• Order of Honour 3rd Class (2006)
• Winner of the Prizvanie (Vocation) National Award ‘The Best Doctor of Russia’ nomination ‘For Breaking a New Medical Ground’ (2006)
• Lopatkin Award Winner ‘For the Contribution to the Development of Russian Urology’ (2007 & 2012)
• Medal ‘For Contribution to International Cooperation’ (2011)
• State Award ‘For Active Citizenship and Valuable Contribution to the Public and Political Life’
• Excellent Worker of Public Health (2012)
• Honoured Scientist of the Russian Federation (2016)
• Certificate of Appreciation ‘For Merit to the Urban Community’ (2019)
Armais Kamalov is a prominent scientist, teacher, top ranking urologist, who have mastered the most advanced treatment of urological diseases, a thought leader home and abroad. He is a well-regarded professional in public and professional communities.

Professor Evgeny Shlyakhto, Director General of the Almazov National Medical Research Centre, Academician of the Russian Academy of Science, President of the Russian Society of Cardiology, Fellow of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.

Elena Zhidkova is the Head of the RZD Medicine network of health centres, a branch of JSC Russian Railways, and General Director of JSC RZD Medicine.
RZD Medicine consists of 134 medical institutions in 75 constituent entities of the Russian Federation and employs more than 60,000 people.
A graduate of Sechenov First Moscow State Medical University with a specialization in General Medicine, Ms. Zhidkova began her career in 2011 at the Morozov Children’s City Clinical Hospital in Moscow, where for over five years she headed up the consultative and diagnostics centres and ran outpatient services.
In 2011, she completed her residency at the Department of Economics and Management at Sechenov First Moscow State Medical University.
In 2010, she completed a course in marketing at Moscow State University of Economics, Statistics and Informatics.
Ms. Zhidkova holds an MBA in Entrepreneurship and Management from the Russian Presidential Academy of National Economy and Public Administration.
In 2019, she earned a Master’s from the Russian Presidential Academy of National Economy and Public Administration.
In 2020, she completed the Executive Master of Public Management (EMPM) talent pool development program.
Ms. Zhidkova carries out extensive research and teaching work. She is a lecturer at the UNESCO Chair “Healthy Lifestyle is the Key to Successful Development” at Y.I. Yevdokimov Moscow State University of Medicine and Dentistry.
Ms. Zhidkova holds a Ph.D. in Medicine, and has published numerous articles, papers and research and methodological works. She is a member of the Board of the Russian Union of Industrialists and Entrepreneurs (RSPP), and Deputy Chair of the RSPP Commission on Healthcare.
She is also a member of the Regional Health Council of the Federation Council of the Russian Federation.
Elena Zhidkova is a recipient of the Order “For Merit to the Fatherland,” II Class, awarded by decree of President of the Russian Federation Vladimir Putin.
On March 4, 2022, Ms. Zhidkova was named the winner of the “Ambassador of Corporate Health” award at the All-Russian Women for Health awards.
In December 2022, she received a letter of thanks from the Head of Military Clinical Hospital No. 1586 of the Ministry of Defence of the Russian Federation, Colonel of the Medical Service Peter Konovalov, for her contribution to the organization and running of donor campaigns for employees of Russian Railways and her volunteer work with Russian military personnel.
On December 19, 2022, Ms. Zhidkova received a letter from the Head of the P.V. Mandryk Central Military Clinical Hospital of the Ministry of Defence of the Russian Federation, Major General of the Medical Service Dr. Pavel Kraynikov, for her humanitarian work.

Education:
1990 — Graduated from Moscow Institute of Chemical Engineering.
2006 — Obtained an MBA degree in political and business communications from Institute of Communication Management (High School of Economics).
Professional experience:
Since Sep. 2010 – Deputy CEO for Sustainable Development and Corporate Communications at METALLOINVEST Management Company LLC
2005 — 2010 – Corporate Communications Director at METALLOINVEST Management Company LLC
1997 — 2005 – Head of Public Affairs Department at EASTLINE Group Management Company
1995 — 1997 – Head of Advertising and Communication Department at Electronic—Design
1993 — 1995 – Head of Advertising Department in VICO Company.

Head of the Industry Competence Center for Ensuring the Organization of Catering, Food Safety and the Development of a Healthy Eating Culture, State Atomic Energy Corporation Rosatom

Education:
2000: Kazan State Financial and Economic Institute (KSFEI, now part of Kazan (Volga region) Federal University
Degree: Finance and Credit
2004: Postgraduate course at KSFEI
2011: Master's Degree from the Russian Presidential Academy of National Economy and Public Administration (RANEPA) in State and Public Administration
2012, 2016, 2017: Advanced training courses at RANEPA in Managing Innovative Development of Industries and Regions, Managerial Skills: Developing Regional Teams, and Application of Flexible Project Management Methods in Russian Authorities.
Graduate of the first stage of the Management Personnel Pool for the Civil Service program (the so-called school of governors)

2005: PhD in Economics from KSFEI
Thesis: Capital Outflow in the System of Economic Security of Modern Russia

Career:
September 1996-October 1998: Deputy Chairman of the student trade union, Kazan State University of Economics and Finance

June 2000-March 2001: Insurance specialist and internal auditor at Industrial Insurance Company, Kazan

2004-2006: Lecturer, Department of Macroeconomics and Economic Theory, Kazan State Financial and Economic Institute

July 2006-May 2010: Deputy director for research, Center for Advanced Economic Research, the Academy of Sciences of Tatarstan

May 2010-October 2014: Deputy Minister of the Economy of Tatarstan

October 2014-February 2018: Minister of the Economy of Tatarstan

February 7, 2018-2020: Chairman of the Government of the Republic of Dagestan

November 18, 2020: Appointed Acting Head of the Republic of Mordovia by an executive order of President of Russia Vladimir Putin

Awards:
Winner of the contest of the Academy of Sciences of Tatarstan for Best Scientist of 2009

Fluent in English
2009: International business English certificate from Cambridge University, United Kingdom

Born on 20 April 1979 in Moscow.
In 2001 Mr. Zubov graduated from the Moscow State University of Culture and Arts, Faculty of Management and Social Information Technologies, the specialty in Information Systems in Social and Cultural Field. Candidate of pedagogical sciences.
From 2000 to 2008 he held management positions related to business development in LLC "Trading House BIBLO-GLOBUS" and was a member of the Supervisory Board of "BIBLIO-GLOBUS" Holding Group.
From 2008 to 2012 he served as Head of Division for Science, Innovation and Information Technology in the Department for Science and Education of the Ministry of Culture of the Russian Federation.
In 2009 Mr. Zubov was promoted to the rank of Third Class State Civil Service Councellor of the Russian Federation.
In 2013 he served as Deputy Head of Department and Head of Division for Monitoring Quality Assessment of Vocational Education in the Department of Public Services of the Federal Service for the Supervision of Education and Science (ROSOBNADZOR).
From 2013 to 2016 Mr. Zubov served as Deputy Head of Division for Information Technologies in the Federal State Unitary Enterprise "Main Production and Commercial Administration for Diplomatic Corps Services at the Ministry of Foreign Affairs of the Russian Federation".
From 2016 to 2018 he worked as Director of the Federal State Budget Institution "Federal Institute of Industrial Property" (FIPS).
From 2018 to 2022 he served as Deputy Head of the Federal Service for Intellectual Property (Rospatent).
In 2020 he was promoted to the rank of Third Class Active State Counsellor of the Russian Federation.
In February 2022 he was appointed as Head of Rospatent.

Founder and Chairman of the Board of Directors of Promomed Group, medical doctor. Petr Bely has more than 25 years of experience in the medical sector and has held senior positions in a number of large pharmaceutical companies. In 2005, he established the Promomed company and in a few years turned it into one of the most dynamically growing players in the Russian pharmaceutical market. Petr Bely regularly participates in scientific forums, conferences and other industry events. He is the author of numerous scientific publications. In March 2021, he was awarded the Pirogov Order for his merits in the field of drug production.

Education:

— Moscow State Medical and Dental University, "Medicine" specialty, training in clinical residency and a full course in "Therapeutics" specialty;
— Candidate of Medical Sciences in the "Internal diseases" specialty.

In 1986, she graduated from Second Leningrad Medical Institute.
In 2004, she received a degree in International Business Management from Russian Presidential Academy of National Economy.
12.2014 – Present Medsi Group, President
05.2010-12.2014 Bashneft, Vice President for Corporate Communications and GR
11.2007-05.2010 Medsi Group, Vice President for Special Projects and Government Relations
02.2006-10.2007 VTB Insurance, First Deputy CEO
03.2005-02.2006 Rosno, Deputy Head of Department of Insurance for Financial Institutions
06.2001-02.2005 Medical-Technological Holding Company, Head of Department

Andrey Bezrukov currently serves as Professor at MGIMO - the preeminent Russian school of Foreign Service. He is also an Advisor to the CEO of “Rosneft” – the largest public oil company in terms of reserves and production.
Among his areas of focus are geopolitics, information security, future studies and international corporate strategy, with particular interest in USA and Eurasia.
Prior to working for “Rosneft” Andrey Bezrukov had a career with Russian government and international consulting companies. He has lived and worked in the USA, Canada and France.
Andrey holds a Master of Public Administration degree from Harvard University’s Kennedy School of Government, an MBA from the Ecole Nationale des Ponts et Chaussees in France, a degree in International Economics from Canada and a degree in History from Tomsk University.
Andrey Bezrukov is an author of books and articles on strategy, international relations and future studies. He is a Member of the Presidium of the Council on Foreign and Defense Policy and an expert of the Valdai Club. He regularly appears on the most watched Russian news programs.

He launched his career in August 2001 at GPB Bank.
Until June 2003, he held the positions of a specialist and a senior specialist in the credit department of the Tomsk branch of the bank.
June 2003 – March 2006, Senior Specialist in the Branch Network Management Department
March 2006 – September 2007, Deputy Head of the Directorate for Coordinating the Regional Network Operations – Head of the Branch Network Management Department
September 2007 – February 2010, Head of the Directorate for Coordinating the Regional Network Operations
February 2010 – May 2011, Deputy Head of the Department
Since May 2011, Vice President of the Bank
Since September 2012, First Vice President of the Bank
Since February 2013, member of the Management Board
Since November 2014, Deputy Chairman of the Management Board
In 2001, he graduated from Tomsk State University with a degree in Management.

Since May 2017 Irina Panarina has been appointed to the position of General Manager of AstraZeneca, Russia and Eurasia. Irina is responsible for AstraZeneca business in Russia & Eurasia Area and she leads AstraZeneca Russia.
Irina Panarina has worked for AstraZeneca since 2009. In October 2015 Irina joined the Russian team as Cardiovascular and Metabolic Disease Business Unit Head. Before coming to Russia, Irina Panarina held the position of General Manager at AstraZeneca Ukraine.
Prior to joining AstraZeneca Irina held regional roles at GSK Pharma headquarters in London, UK.
Irina Panarina has work experience in marketing, product portfolio management, people development.
Irina Panarina has degrees from Newcastle University & South Bank University. She also holds MBA degree from INSEAD Business School.

Yuriy Saprykin graduated from Department of Applied Mathematics at Kuban State University in Systems Programming. He was a Deputy to the Krasnodar Territory Legislative Council, where he was a member of the Science and Education Committee. In this position, he focused on legislation on science and innovation, communications between institutes and research facilities and innovation infrastructure.
2013: Deputy Head of the Federal Agency for Youth Affairs under the Ministry of Education and Science, where he oversaw innovation and information projects, as well as volunteering in sports etc. 2014: joined Skolkovo Technopark as Deputy CEO. He was appointed Vice-President Development of Russian Far East in 2016 and Vice-President for Regional and International Development in 2016.

Born on July 17, 1949, in Leningrad (now St Petersburg). 1971 – graduated from Zhdanov Leningrad State University; Doctor of Physics and Mathematics. 1971-1991 – junior researcher, laboratory head, deputy director for research, leading researcher at the Ioffe Physical Technical Institute of the Soviet Academy of Sciences, Leningrad. 1991-1993 – Vice President of Advanced Technology Centre, St Petersburg. 1994-2001 – Director of Regional Foundation for Scientific and Technological Development, St Petersburg. From 2000 – Chairman of the Academic Council of the Centre for Strategic Research North-West Foundation. 2001-2002 – Deputy Minister of Industry, Science and Technology of the Russian Federation. From June 2002 – First Deputy Minister of Industry, Science and Technology of the Russian Federation. From December 2003 – Acting Minister of Industry, Science and Technology of the Russian Federation. March 9, 2004 – appointed Minister of Education and Science of the Russian Federation. Since May 21, 2012 – Aide to the President of the Russian Federation. State award – Honorary Diploma of the Government of the Russian Federation.

Natalia Popova, First Deputy СEO of the Non-State Development Institute “Innopraktika”, President of Vision Media Center LLC, graduated from Finance Academy under the Government of the Russian Federation and the Faculty of Foreign Languages and Area Studies of Moscow State University. Natalia is a member of the Boards of Directors of ITECMA LLC, VEB Ventures LLC, also the Supervisory Boards of the INTC Composite Valley Foundation and MSP Bank JSC, as well as the Board of Trustees of the School Unit of the “Phystech XXI” cluster and the autonomous non-profit educational organization “Phystech-lyceum” named after P.L. Kapitsa. In addition, she is the chairman of the board of directors of IAC OJSC, the co-chairman of the Coordinating Council for the introduction of innovative Russian products into the production and economic activities of Gazprom. Natalia is a member of the Council for the Implementation of the Federal Scientific and Technical Program for the Development of Agriculture for 2017-2025; the working group which provide support to small and medium businesses in high-tech sectors of the economy, including those introducing innovations, implementing projects in the field of import substitution and (or) producing export products and services; to the Expert council for the development of financial instruments and non-financial measures to support enterprises of Russia's defense industry under the Commission of the State Duma on legal support for the development of organizations in the defense industry of Russia. Natalia is the originator and the host of Innopraktika media projects, including such projects as “Dom uchenyh” (lit.: The House of Scientists) in cooperation with “Kultura” TV channel, “Nauka” (lit.: Science) in cooperation with “Russia-24” TV channel, also a member of the committee for preparation and implementation of the global project "Russian Seasons". Since December 2019, Natalia Popova has been holding the position of the Ombudsman representing interests of high-tech leading companies, established on the Commissioner for Entrepreneurs' Rights at the President of the Russian Federation institution basis.

Born on March 15, 1973 in Jaipur, India. Russian citizen.
Graduated from Birla High School in Pilani. In 1992 started his higher education in Russia, at Irkutsk State Medical University. Later graduated from the Far Eastern Federal University, majoring in Finance and Credit. Married, with three children.
Founder of Pharmasyntez, member of the Leaders’ Club to Promote Business Initiatives (a non-profit partnership), Co-Chairman of the Business Council for Cooperation with India, participant in several investment forums and business missions.
Pharmasyntez manufactures medicinal drugs for socially significant diseases, such as tuberculosis, HIV/AIDS, cancer, hepatitis and diabetes. The company’s profile includes over 113 various pharmaceutical forms and dosages – caps, pills, granules, IV solutions, sterile dry powders, solutions for injection and lyophilisates. Currently Pharmasyntez has five GMP compliant manufacturing facilities in the following Russian cities: Saint Petersburg, Tyumen, Bratsk, Irkutsk and Ussuriysk. The company employs over 1500 qualified specialists.
Pharmasyntez was number one Russian pharmaceutical manufacturer based on hospital purchases in 2016 (and No. 5 out of all pharmaceutical manufacturers, based on hospital purchases records). In 2016 it also became the fastest growing Russian manufacturing company with the revenue of 12 billion, which has doubled in comparison with 2014.
Currently Pharmasyntez is Russia’s leader in manufacturing medicinal agents for tuberculosis, retrovirus and cancer. Farmasintez does innovative R&D and exports pharmaceutical agents from Russia. The company is Irkutsk’s biggest tax payer.

Starting from December 2021, Mr. Sarkisov has been heading the Voskhod Venture Fund (Interros Group).

In 2018ؘ—2021 — Head of the Far East High Technologies Fund.

2014-2018 Ruslan was Deputy to CEO at the Far East Developpment Fund responsible for launching Far East High Technologies Fund and projects in logistics, housing and Utility Infrastructure and manufacturing industry.
2011-2013 Ruslan was Senior Vice-President at the Russian Direct Investment Fund (RDIF) where participated in the implementation of investment projects in the telecommunications and commodities sectors as well as in the creation of the Russian-Chinese investment fund with a capital of 2 billion dollars.
Since 2002, Ruslan has held various positions in Russian and international companies (Ernst & Young, Basic Element, CentreInvest Capital Partners, Rusnano.
snano.

Candidate of Biological Sciences

- Director, Institute of Personalized Medicine, National Medical Research Centre for Endocrinology, Ministry of Health of the Russian Federation
- Executive Director, Center for Living Systems and Biopharmaceutical Engineering; Head, Genome Engineering Lab, Moscow Institute of Physics and Technology (MIPT)

World-class geneticist, Moscow State University alumnus, worked at the University of Chicago and Harvard Medical School. His research focuses on applied projects in the realm of genetics and bioinformatics for agro- and biomedicine.

___________________________________________________________________

Education:
In 2004, he graduated with honours from Moscow State University with a degree in biochemistry, specializing in plant, animal, and human viruses.
In 2008, he successfully defended his Candidate’s dissertation on genetics and stem cells at the Institute of Gene Biology and the Vavilov Institute of General Genetics of the Russian Academy of Sciences.
From 2006 to 2015, he held postdoc fellowships with the University of Chicago and the Boston Children's Hospital (Harvard University).

Professional experience:

Biomedical scientist specializing in molecular biology, genetics, microbiology, and stem cell biology, with experience in flow cytometry, especially of hematopoietic stem cells and immune cells. Over 10 years of experience in creating genetically modified animals, experience working with animal models, including the organization and management of gnotobiotic vivarium facilities at the University of Chicago.

● From 2020 — Executive Director, Center for Living Systems and Biopharmaceutical Engineering, MIPT
An MIPT scientific and educational centre, an extension of the Genome Engineering and Orphan Diseases Therapy laboratories, focused on conducting basic and applied research in the realm of genome engineering, gene therapy development, bioinformatics, and related fields
● 2019–2020 — Director, Centre for Genomic Technology and Bioinformatics, MIPT. A scientific and educational centre created through the Science National Project, part of the Kurchatov Genome Centre, in the domains of ‘Genetic Technologies for Agricultural Development’ and ‘Gene Technologies for Industrial Microbiology’.
● From 2016 — Head, Genome Engineering Lab, MIPT. Research: editing human stem and somatic cells to create therapies for oncological, autoimmune, and infectious diseases, developing technological platforms for editing animal and plant genomes, e.g., creating animals and plants that are resistant to viral and bacterial pathogens, translating gene editing technologies (CRISPR-based technologies) to applied research projects.
● 2015 — Gene editing laboratory with a focus on creating genetic animal models in the fields of virology and immunology, regenerative medicine, stem cell biology, at the Burnasyan Federal Medical Biophysical Centre of the Federal Medical Biological Agency, at the MIPT Laboratory of Pre-clinical Research. Research: creating new animal models for studying the biology of hematopoietic stem cells, the interactions of innate and acquired immunity with microflora and pathogenic bacteria and viruses, gene editing of hematopoietic stem cells using CRISPR/Cas9 technology to create therapies for diseases previously thought to be incurable such as HIV and even inherited blood disorders (sickle-cell anemia).
● 2015 — Visiting Scholar, Immanuel Kant Baltic Federal University. Organizing scientific and educational activities, developing a laboratory complex, teaching by way of mentoring undergrad students, graduate students, and staff.
● 2011–2015 — Postdoctoral Fellow, Boston Children’s Hospital, Harvard University, USA. Research: identifying combinations of transcription factors for reprogramming differentiated blood cells into hematopoietic stem cells to develop clinical protocols for creating hematopoietic blood stem cells during transplantation, applying CRISPR/Cas9 technology to edit genomes, creating animal models for studying the biology of hematopoietic stem cells, the role of miR-142 in hematopoiesis.
● 2006–2011 — Postgraduate/Postdoctoral Fellow, University of Chicago, Chicago, USA. Research: the role of intestinal microflora in the development of type 1 diabetes, the creation of animal models for studying the role of PAMPs (DAMPs) in the development of autoimmunity, the role of intestinal microflora and regulatory T cells in suppressing the development of an autoimmune response.
● 2005–2008 — Postgraduate, Institute of Gene Biology and Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia. Research: epigenetic regulation of key transcription factors regulating the pluripotency of embryonic stem cells and tissue-specific differentiation.

Research Interests:
Biochemistry; genetics; molecular biology; medicine; immunology; pharmacology, toxicology, and pharmaceutics; regenerative medicine; stem cells; bioinformatics; engineering

Financial expert, economist, MBA in innovation management; expert in project management and business development

Ms. Popova, M.D., has a degree in medicine and prophylactics, professor in medical hygiene.
Worked as an epidemiologist, chief of epidemiology at Budennovsk hospital, chief epidiemologist in State Center in Serpukhov and Pushino, deputy head of Rospoterbnadzor in Moscow oblast, head of HR or Rospoterbnadzor and deputy chief of Rospotrebnadzor .
After a decree of the government of Russian Federation government N1931 temporary acted as chief of Federal Agency for consumer protection and human wellbeing from October 23, 2013.
Following a decree of the government of Russian Federation N571-p appointed head of Rospoterbnadzor.
Married, has two children

Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks

Born 7 July 1960 in Goгky oblast.
In 1985, graduated Ivanovo State Medical Institute with honours, majoring in Paediatrics. Worked her way up from a rural hospital nurse to Chief Physician of Teykovo Central Regional Hospital (Ivanovo Oblast).
In 1999, elected Deputy of the 3rd State Duma of Ivanovo single member electoral district No.78 (Ivanovo oblast), also elected Deputy of the 4th, 5th, and 6th State Duma of the Federal Assembly of the Russian Federation.
Acted as Deputy Head of the State Duma Committee for Healthcare and Sports, Head of the State Duma Committee for Healthcare, First Deputy Head of the United Russia fraction at the State Duma of the Federal Assembly of the Russian Federation.
While in the State Duma, was a member of interagency working group on the Healthcare priority national project at the Russian Federation Presidential Council for the Implementation of the Priority National Projects, State Duma Committee for the Juvenile Affairs and Protection of their Rights and Governmental Committee for Combating Drug Abuse and Illegal Drug Trafficking, as well as acted as Deputy Head of State Duma Committee for Technical Regulation.
Doctor of Medicine, Honoured Doctor of the Russian Federation, Professor, co-author of over 59 research publications, 7 textbooks, 6 patents. The winner of the Russian Federation Governmental Award in the field of science and technology. In 2001, graduated Moscow State Social University specializing in Law. Holds top qualification category in Public Health. Chair of the Department on outpatient and social paediatrics at Pirogov Russian National Research Medical University (RNRMU), the Ministry of Health of the Russian Federation.
Decorated with the Order of Honour, Medal of the 2nd degree Order of Service to the Fatherland, Medal of Merit for the National Healthcare; received Citation from Valentina Matvienko, the Chair of the Federation Council of the Federal Assembly of the Russian Federation.
Appointed Deputy Minister of Healthcare of the Russian Federation by Government Order No.1010-р of 18 June 2012.

Olga Krivonos – Doctor of Medical Sciences, Honoured Physician of the Russian Federation.
After graduation from the institute, internship and clinical residency in 1997, she worked as a neurologist and assistant professor at the Department of Neurology.
From 1999 to 2003, she took full-time postgraduate courses in neurology at the Russian Medical Academy of Postgraduate Education in Moscow.
Following her postgraduate studies, from 2003 to 2008 she was Head of the Neurology Department and Deputy Chief Physician of the Medical Department, Avetik Burnasyan Clinical Hospital No. 6, Federal Medical Biological Agency of Russia.
From 2008 to 2012, she was Undersecretary and Director of the Medical Prevention Services, Medical Care and Health Care Development Department, Russian Ministry of Health and Social Development.
From 2012 to 2013, she was Deputy Head of Department, Administration of the President of the Russian Federation.
From 2013 to 2018, she worked in the Accounts Chamber of Russia as Director of the Department for Expert Analysis and Oversight of Federal Budget Expenditures in Health Care, Education, Culture, Cinematography, and the Federal Compulsory Medical Insurance Fund.
Since 2019, she has held the position of Deputy Chief of Government Staff, Government of the Russian Federation. She oversees state policy in health care, social and pension benefits, medical and social insurance, public sanitary and epidemiological well-being, the development of medical science, the pharmaceutical and medical industry, biotechnologies, the genetic technology programme and other issues in accordance with the approved authority.

Chief Sustainability Officer and Member of the Executive Team, RUSAL, one of the largest global producers of aluminium, including low carbon aluminum (LCA) marketed under ALLOW brand. Irina is an accomplished professional with a 30-year leadership experience in both public and private sectors varying from mass media, banking, fast moving consumer goods to metallurgy. She was instrumental to have set up such platforms as Digital, Low Carbon and Science-Based Economy Taskforce of the Foreign Investors Advisory Council (FIAC) under the auspices of the Russian Prime Minister, Sustainable Business Lab at SKOLKOVO Moscow School of Management, ‘Green Brands League’ under the auspices of the Russian Quality System (Roskachestvo), and Commission on Business Ethics of the Russian Managers Association. Irina chairs Sustainability and ESG Committee of the Russian Managers Association, Environment and Climate Committee of the National ESG Alliance, and is a Vice President Sustainability in the Russian Business Ethics Network.

Born in Petropavlovsk-Kamchatsky, Kamchatka Territory.
She graduated from Ordzhonikidze State Management Academy in “Global Economics”.
1993–1995: Finance Director, AOZT Salvis.
1995–2000: Various posts at Arthur Andersen / Ernst and Young.
2000–2009: Financial controller, head of internal audit, Finance Director, Sonic Duo (MegaFon Moscow).
2009–2010: Vice-President of Finance, OOO Holding Company Rosgosstrakh.
2010–2012: Worked for AFK Sistema (Executive Vice-President for finance and investments at OAO AFK Sistema, Deputy General Director, head of finance, investments, and economics at OAO RTI).
2012: Adviser to the Head of the Federal Agency for State Property Management.
2013–2017: Deputy Head of the Federal Agency for State Property Management.
She holds the Russian Federation Civil Service grade rank of Third Class Active State Adviser of the Russian Federation.
Since April 25, 2017: Corporate Director of the Agency for Strategic Initiatives.

Kira Zaslavskaya has more than 10 years of experience in the medical sector. She started her career as a medical representative and now she is a top manager at a major pharmaceutical company.
In 2009, she joined the team of Promomed Group. As Director for New Products, she is responsible for the product portfolio development strategy, the introduction of new technologies in the development of medicines, the organization of preclinical and clinical trials and the launch of products on the market.
Kira Zaslavskaya participated in the implementation of the world’s largest observational post-marketing study in endocrinlogy of the efficacy and safety of Reduxin®, as well as in the development, study and market launch of Areplivir®, the drug for coronavirus infection.
She graduated from the Mendeleev Russian University of Chemical Technology and passed postgraduate training program at the Nesmeyanov Institute of Organoelement Compounds of the Russian Academy of Sciences. She is an author of numerous scientific papers, a competent speaker at industry events.

Born on March 15, 1973 in Jaipur, India. Russian citizen.
Graduated from Birla High School in Pilani. In 1992 started his higher education in Russia, at Irkutsk State Medical University. Later graduated from the Far Eastern Federal University, majoring in Finance and Credit. Married, with three children.
Founder of Pharmasyntez, member of the Leaders’ Club to Promote Business Initiatives (a non-profit partnership), Co-Chairman of the Business Council for Cooperation with India, participant in several investment forums and business missions.
Pharmasyntez manufactures medicinal drugs for socially significant diseases, such as tuberculosis, HIV/AIDS, cancer, hepatitis and diabetes. The company’s profile includes over 113 various pharmaceutical forms and dosages – caps, pills, granules, IV solutions, sterile dry powders, solutions for injection and lyophilisates. Currently Pharmasyntez has five GMP compliant manufacturing facilities in the following Russian cities: Saint Petersburg, Tyumen, Bratsk, Irkutsk and Ussuriysk. The company employs over 1500 qualified specialists.
Pharmasyntez was number one Russian pharmaceutical manufacturer based on hospital purchases in 2016 (and No. 5 out of all pharmaceutical manufacturers, based on hospital purchases records). In 2016 it also became the fastest growing Russian manufacturing company with the revenue of 12 billion, which has doubled in comparison with 2014.
Currently Pharmasyntez is Russia’s leader in manufacturing medicinal agents for tuberculosis, retrovirus and cancer. Farmasintez does innovative R&D and exports pharmaceutical agents from Russia. The company is Irkutsk’s biggest tax payer.

Professor Evgeny Shlyakhto, Director General of the Almazov National Medical Research Centre, Academician of the Russian Academy of Science, President of the Russian Society of Cardiology, Fellow of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.

Apolikhin O.I. is a graduate of Voronezh State Medical Institute and has received his MD from the Scientific Research Institute of urology of the Health Ministry of Russia. He extended his education with several abroad trainings: Medical Technical University (ACTIM) France, Medical and Economic faculty, course in health care economics and new technologies and modern equipment utilization. Oxford University (England), MBA faculty, course in medical ethics and administrative law in health care. Oxford University (England), course in evidence based medicine. Professor Apolikhin is actively involved in state health care structure being chief specialist in Reproductive Health of the Ministry of Health Care of Russia. He systematically holds scientific, organizational and methodical activity in reproductive health in Russian regions. Professor Apolikhin has been recognized nationally and internationally through his international memberships which include European Urological Association, American Urological Association and Royal Society of Medicine (UK). He studied Administrative ethical issues in health care at Oxford University, where he also received MSc in evidence-based health care. Professor Apolikhin holds editorial positions on several well-respected journals, including Russian Journal of Urology. He has authored and co-authored more than 500 articles, edited and co-edited 10 books, has multiple multimedia presentations to his credit. His extensive experience in the field of urology and andrology has afforded him the opportunity to participate in academic activities, meetings and courses as a speaker and chairperson. Fields of his interest are postgraduate medical education upgrading, modernization of Russian health care system, men’s health evaluation and management.

Doctor of Economic Sciences, Professor.
Head of the Department of Health and Self-Preservation Behavior, Institute of Demographic Research, Federal Research Sociological
center of the Russian Academy of Sciences

President of State-Owned Autonomous Medical Facility Moscow Research and Practical Centre for Medical Rehabilitation and Reconstructive and Sports Medicine of the Moscow Department of Healthcare, full member of the Russian Academy of Sciences, Doctor of Medicine Alexander Rasumov was born in 1944 in Sheperovo, Chaussky District, Mogilev Region. From 1960 to 1970, he studied at the Chernigov Higher School for Air Force Pilots and Engineers and the Grodno Institute of Medicine and the Saratov Institute of Medicine. From 1970 to 1990, he worked at the Defence Ministry’s Institute of Aviation and Space Medicine. From 1990 to 1992: Director, Research and Production Centre Rabotosposobnost of the USSR Ministry of Oil and Gas Construction. From 1992 to 1998: CEO, Moscow Centre for Health Problems under the Government of Moscow. From 1998 to 2010: Director, Federal State-Owned Institution Russian Research Centre for Rehabilitative Medicine and Resorts of the Ministry of Healthcare. Holds the title of Distinguished Scientist of the Russian Federation, laureate of the Prize of the Government of the Russian Federation, President of the International University of Rehabilitative Medicine, of the National Resort Association and of the Russian Society of Rehabilitative Medical Doctors, member of the Board of the National Medical Chamber, member of the Russian-German Council, Professor Emeritus of Liverpool University, Russian representative in and member of the WHO European Committee for Global Health Policy, Chairman of the FEMTEC Medical Commission. Alexander Rasumov led the drafting and approval of the Concept for State Policy on Resort Development in the Russian Federation. He has been decorated with the Order of Service to Motherland in the Armed Forces 3rd Degree, the Order of Friendship, the Medal for Valiance in Combat, etc. Aleander Rasumovis a laureate of the Profession Life international prize, the Mikhail Lomonosov Prize in the field of Science and Education and the Russian Ministry of Healthcare and Social Development Russia’s Best Doctor: The Mission prize, recipient of a diploma of the N.A. Semashko Russian Academy of Medical Sciences prize for the best paper on the theory and history of healthcare.